FOLD logo

Amicus Therapeutics (FOLD) Selling, general & administrative expenses

annual SGA:

$323.38M+$48.11M(+17.48%)
December 31, 2024

Summary

  • As of today (June 2, 2025), FOLD annual SGA is $323.38 million, with the most recent change of +$48.11 million (+17.48%) on December 31, 2024.
  • During the last 3 years, FOLD annual SGA has risen by +$130.67 million (+67.81%).
  • FOLD annual SGA is now at all-time high.

Performance

FOLD SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDincome statement metrics

quarterly SGA:

$91.83M+$5.16M(+5.95%)
March 31, 2025

Summary

  • As of today (June 2, 2025), FOLD quarterly SGA is $91.83 million, with the most recent change of +$5.16 million (+5.95%) on March 31, 2025.
  • Over the past year, FOLD quarterly SGA has increased by +$3.80 million (+4.31%).
  • FOLD quarterly SGA is now at all-time high.

Performance

FOLD quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDincome statement metrics

TTM SGA:

-$11.01B-$29.37M(-0.27%)
March 31, 2025

Summary

  • As of today (June 2, 2025), FOLD TTM SGA is -$11.01 billion, with the most recent change of -$29.37 million (-0.27%) on March 31, 2025.
  • Over the past year, FOLD TTM SGA has dropped by -$11.29 billion (-3903.51%).
  • FOLD TTM SGA is now -29386.73% below its all-time high of -$37.32 million.

Performance

FOLD TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

FOLD Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+17.5%+4.3%-3903.5%
3 y3 years+67.8%+58.0%-5492.0%
5 y5 years+90.4%+128.3%-6738.7%

FOLD Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+67.8%at high+94.3%-21.6%at low
5 y5-yearat high+106.8%at high+165.0%-59.0%at low
alltimeall timeat high+4602.4%at high+3122.0%<-9999.0%at low

FOLD Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Mar 2025
-
$91.83M(+6.0%)
$327.18M(+1.2%)
Dec 2024
$323.38M(+17.5%)
$86.67M(+15.4%)
$323.38M(+5.4%)
Sep 2024
-
$75.11M(+2.1%)
$306.95M(+3.2%)
Jun 2024
-
$73.58M(-16.4%)
$297.50M(+2.8%)
Mar 2024
-
$88.03M(+25.3%)
$289.34M(+5.1%)
Dec 2023
$275.27M(+29.2%)
$70.24M(+7.0%)
$275.27M(+6.2%)
Sep 2023
-
$65.65M(+0.3%)
$259.31M(+7.6%)
Jun 2023
-
$65.42M(-11.5%)
$240.93M(+5.3%)
Mar 2023
-
$73.96M(+36.3%)
$228.88M(+7.4%)
Dec 2022
$213.04M(+10.6%)
$54.27M(+14.8%)
$213.04M(-1.5%)
Sep 2022
-
$47.27M(-11.4%)
$216.37M(+0.5%)
Jun 2022
-
$53.38M(-8.2%)
$215.20M(+5.4%)
Mar 2022
-
$58.12M(+0.9%)
$204.10M(+5.9%)
Dec 2021
$192.71M(+23.2%)
$57.60M(+24.9%)
$192.71M(+7.8%)
Sep 2021
-
$46.11M(+9.1%)
$178.79M(+4.8%)
Jun 2021
-
$42.28M(-9.5%)
$170.54M(+4.7%)
Mar 2021
-
$46.73M(+7.0%)
$162.92M(+4.2%)
Dec 2020
$156.41M(-7.9%)
$43.69M(+15.4%)
$156.41M(+0.2%)
Sep 2020
-
$37.85M(+9.2%)
$156.02M(-1.2%)
Jun 2020
-
$34.66M(-13.8%)
$157.85M(-4.8%)
Mar 2020
-
$40.22M(-7.1%)
$165.77M(-2.4%)
Dec 2019
$169.86M(+33.5%)
$43.30M(+9.1%)
$169.86M(+2.7%)
Sep 2019
-
$39.68M(-6.8%)
$165.33M(+5.0%)
Jun 2019
-
$42.58M(-3.9%)
$157.51M(+9.3%)
Mar 2019
-
$44.30M(+14.3%)
$144.11M(+13.3%)
Dec 2018
$127.20M(+43.5%)
$38.77M(+21.6%)
$127.20M(+8.7%)
Sep 2018
-
$31.87M(+9.2%)
$117.02M(+9.6%)
Jun 2018
-
$29.17M(+6.5%)
$106.80M(+10.2%)
Mar 2018
-
$27.40M(-4.1%)
$96.94M(+9.3%)
Dec 2017
$88.67M(+24.6%)
$28.58M(+32.0%)
$88.67M(+12.6%)
Sep 2017
-
$21.65M(+12.1%)
$78.77M(+5.6%)
Jun 2017
-
$19.31M(+0.9%)
$74.59M(+0.0%)
Mar 2017
-
$19.13M(+2.4%)
$74.58M(+4.8%)
Dec 2016
$71.15M(+50.5%)
$18.68M(+6.9%)
$71.15M(+2.1%)
Sep 2016
-
$17.47M(-9.5%)
$69.66M(+3.1%)
Jun 2016
-
$19.30M(+22.9%)
$67.56M(+19.5%)
Mar 2016
-
$15.70M(-8.7%)
$56.54M(+19.6%)
DateAnnualQuarterlyTTM
Dec 2015
$47.27M(+128.2%)
$17.19M(+11.8%)
$47.27M(+32.8%)
Sep 2015
-
$15.37M(+85.7%)
$35.59M(+39.6%)
Jun 2015
-
$8.28M(+28.8%)
$25.49M(+16.0%)
Mar 2015
-
$6.43M(+16.5%)
$21.97M(+6.0%)
Dec 2014
$20.72M(+9.7%)
$5.52M(+4.7%)
$20.72M(+4.6%)
Sep 2014
-
$5.27M(+10.9%)
$19.80M(+3.3%)
Jun 2014
-
$4.75M(-8.2%)
$19.17M(-0.4%)
Mar 2014
-
$5.18M(+12.4%)
$19.25M(+1.9%)
Dec 2013
$18.89M(-2.4%)
$4.61M(-0.6%)
$18.89M(+0.8%)
Sep 2013
-
$4.63M(-4.0%)
$18.74M(-1.9%)
Jun 2013
-
$4.83M(+0.1%)
$19.10M(-4.9%)
Mar 2013
-
$4.82M(+8.3%)
$20.09M(+3.8%)
Dec 2012
$19.36M(-2.6%)
$4.46M(-10.8%)
$19.36M(+2.9%)
Sep 2012
-
$5.00M(-14.2%)
$18.83M(+0.8%)
Jun 2012
-
$5.82M(+42.1%)
$18.67M(-4.6%)
Mar 2012
-
$4.09M(+4.5%)
$19.57M(-1.5%)
Dec 2011
$19.88M(+26.9%)
$3.92M(-19.1%)
$19.88M(+0.5%)
Sep 2011
-
$4.84M(-28.0%)
$19.79M(+5.0%)
Jun 2011
-
$6.72M(+52.7%)
$18.84M(+16.7%)
Mar 2011
-
$4.40M(+15.1%)
$16.14M(+3.0%)
Dec 2010
$15.66M(-21.6%)
$3.82M(-1.8%)
$15.66M(-3.2%)
Sep 2010
-
$3.89M(-3.2%)
$16.18M(-7.6%)
Jun 2010
-
$4.02M(+2.4%)
$17.50M(-6.4%)
Mar 2010
-
$3.92M(-9.5%)
$18.70M(-6.4%)
Dec 2009
$19.97M(+1.6%)
$4.34M(-16.8%)
$19.97M(-3.2%)
Sep 2009
-
$5.22M(-0.1%)
$20.63M(+4.3%)
Jun 2009
-
$5.22M(+0.5%)
$19.78M(+0.5%)
Mar 2009
-
$5.20M(+4.1%)
$19.67M(+0.0%)
Dec 2008
$19.67M(+28.7%)
$4.99M(+14.2%)
$19.66M(-1.5%)
Sep 2008
-
$4.37M(-14.6%)
$19.96M(+2.1%)
Jun 2008
-
$5.12M(-1.3%)
$19.54M(+11.0%)
Mar 2008
-
$5.19M(-1.9%)
$17.61M(+15.3%)
Dec 2007
$15.28M(+24.4%)
$5.28M(+33.6%)
$15.28M(+52.9%)
Sep 2007
-
$3.95M(+24.0%)
$9.99M(+65.5%)
Jun 2007
-
$3.19M(+11.9%)
$6.04M(+111.9%)
Mar 2007
-
$2.85M
$2.85M
Dec 2006
$12.28M(+78.5%)
-
-
Dec 2005
$6.88M
-
-

FAQ

  • What is Amicus Therapeutics annual SGA?
  • What is the all time high annual SGA for Amicus Therapeutics?
  • What is Amicus Therapeutics annual SGA year-on-year change?
  • What is Amicus Therapeutics quarterly SGA?
  • What is the all time high quarterly SGA for Amicus Therapeutics?
  • What is Amicus Therapeutics quarterly SGA year-on-year change?
  • What is Amicus Therapeutics TTM SGA?
  • What is the all time high TTM SGA for Amicus Therapeutics?
  • What is Amicus Therapeutics TTM SGA year-on-year change?

What is Amicus Therapeutics annual SGA?

The current annual SGA of FOLD is $323.38M

What is the all time high annual SGA for Amicus Therapeutics?

Amicus Therapeutics all-time high annual SGA is $323.38M

What is Amicus Therapeutics annual SGA year-on-year change?

Over the past year, FOLD annual SGA has changed by +$48.11M (+17.48%)

What is Amicus Therapeutics quarterly SGA?

The current quarterly SGA of FOLD is $91.83M

What is the all time high quarterly SGA for Amicus Therapeutics?

Amicus Therapeutics all-time high quarterly SGA is $91.83M

What is Amicus Therapeutics quarterly SGA year-on-year change?

Over the past year, FOLD quarterly SGA has changed by +$3.80M (+4.31%)

What is Amicus Therapeutics TTM SGA?

The current TTM SGA of FOLD is -$11.01B

What is the all time high TTM SGA for Amicus Therapeutics?

Amicus Therapeutics all-time high TTM SGA is -$37.32M

What is Amicus Therapeutics TTM SGA year-on-year change?

Over the past year, FOLD TTM SGA has changed by -$11.29B (-3903.51%)
On this page